Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Bacterial viability in dry-surface biofilms in healthcare facilities 10.1016/j.jhin.2023.11.004
Cognitive dysfunction after COVID-19 10.1136/bmj-2023-075387
The effect of the urban exposome on COVID-19 health outcomes 10.1016/j.envres.2023.117351
Emerging enterovirus A71 subgenogroup B5 causing severe hand, foot, and mouth disease, Vietnam, 2023 10.3201/eid3002.231024
Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United States 10.1186/s12879-023-08958-7
Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells 10.1073/pnas.231585712
Favipiravir for treating COVID‐19 (new Cochrane intervention review) 10.1002/14651858.CD015219.pub2
First global report about the prevalence of multi-drug resistant Haemophilus influenzae 10.1186/s12879-023-08930-5
Impact of antibiotic exposure on antibiotic-resistant Acinetobacter baumannii isolation in intensive care unit patients 10.1016/j.jhin.2023.11.002
Measles outbreaks: Investing in patient relationships through GP continuity will be key to boosting MMR confidence 10.1136/bmj.q221
Oral simnotrelvir for adult patients with mild-to-moderate COVID-19 10.1056/NEJMoa2301425
Outcomes of SARS-CoV-2 and seasonal viruses among children hospitalized in Brazil 10.1542/peds.2023-064326
Relationship between human papillomavirus and serum vitamin D levels 10.1186/s12879-024-09006-8
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period 10.1016/S2666-5247(23)00336-1
SARS-CoV-2 vaccination and neuroimmunological disease 10.1001/jamaneurol.2023.5208
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency 10.1126/scitranslmed.adk1599
Sink interventions in the ICU to reduce risk of infection or colonization with Gram-negative pathogens 10.1016/j.jhin.2023.10.011
Success from the South: the rotavirus vaccine story and its lessons 10.1016/S0140-6736(23)02520-5
Syphilis complicating pregnancy and congenital syphilis 10.1056/NEJMra2202762
Tuberculosis (updated NICE guideline NG33)
When the answer is a maybe: a retrospective review of indeterminate SARS-CoV-2 results and their associations 10.1016/j.jhin.2023.07.004
Sources used: BMC Infectious Diseases (Jan); BMJ (1st Feb); Cochrane Library (Jan-Feb); Emerging Infectious Diseases (Feb); Environmental Research (Jan); JAMA (Jan); Journal of Hospital Infection (Jan-Feb); Lancet, The (6th-12th Jan); Lancet Microbe, The (Jan); NEJM (18th Jan); NICE website (Jan-Feb); Pediatrics (Jan); PNAS (Jan); Science Translational Research (Jan)
An atlas of continuous adaptive evolution in endemic human viruses DOI: 10.1016/j.chom.2023.09.012
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients DOI: 10.1016/j.ijid.2023.09.021
Different antibiotic treatments for group A streptococcal pharyngitis (updated Cochrane intervention review) DOI: 10.1002/14651858.CD004406.pub6
Epidemiology and outcomes of vancomycin-resistant enterococcus infections DOI: 10.1016/j.jhin.2023.09.008
Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019 DOI: 10.1016/j.ijid.2023.09.003
Estimating the global impact of rotavirus vaccines on child mortality DOI: 10.1016/j.ijid.2023.10.005
Fossil-fuel pollution and climate change: waterborne diseases that are sensitive to climate variability and climate change DOI: 10.1056/NEJMra2300794
Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic DOI: 10.1016/j.ijid.2023.10.001
Heating, ventilation, and air-conditioning systems in healthcare DOI: 10.1016/j.jhin.2023.08.012
Masks during pandemics caused by respiratory pathogens—evidence and implications for action DOI: 10.1001/jamanetworkopen.2023.39443
Mental health: the invisible effects of neglected tropical diseases DOI: 10.1038/d41586-023-02973-z
National public health response to an outbreak of toxigenic Corynebacterium diphtheriae among asylum seekers in England, 2022 DOI: 10.1016/S2468-2667(23)00175-5
Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19 (updated Cochrane intervention review) DOI: 10.1002/14651858.CD015395.pub3
Potential population-level effectiveness of one-dose HPV vaccination in low- and middle-income countries DOI: 10.1016/S2468-2667(23)00180-9
Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia DOI: 10.1016/j.jhin.2023.09.017
Scoping review on the efficacy of filter and germicidal technologies for capture and inactivation of micro-organisms and viruses DOI: 10.1016/j.jhin.2023.08.026
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management (updated NICE guideline NG237)
Who should be screened for carbapenemase-producing Enterobacterales and when? DOI: 10.1016/j.jhin.2023.09.018
Sources used: Cell Host and Microbe (Oct); Cochrane Library (Nov); International Journal of Infectious Diseases (Dec); JAMA Network Open (Oct); Journal of Hospital Infection (Nov, Dec); Lancet Public Health, The (Oct); Nature Outlook: Neglected Tropical Diseases (Oct); NEJM (7th Dec); NICE website (Nov); Research Square (Oct)